First‐Line PVI‐Linear Plan With Pulsed Field Ablation and Vein of Marshall Ethanol Infusion in Persistent Atrial Fibrillation: Safety, Feasibility, and Mitral Isthmus Workflow Optimization

医学 肺静脉 心房颤动 烧蚀 外科 导管消融 心脏病学 内科学 静脉 心房颤动消融 前瞻性队列研究 深静脉 房性心动过速 心脏消融
作者
Antoine Da Costa,Marion Murat,Cédric Yvorel,Cécile Romeyer,Rayan Mohammed,Antoine Carmaux,Kasra Azarnouch,Nathalie Grand,Taïna Barre,Marouane Bouhkris,Karim Bénali
出处
期刊:Journal of Cardiovascular Electrophysiology [Wiley]
被引量:1
标识
DOI:10.1111/jce.70434
摘要

ABSTRACT Introduction Different ablation strategies and energy sources have been developed for the treatment of persistent atrial fibrillation (PeAF), but the optimal early management remains controversial. In patients with PeAF, the safety and efficacy of an early linear strategy combining pulsed field ablation (PFA) with vein of Marshall ethanol infusion (VOMEI) have not yet been evaluated. Objective This prospective cohort study aimed to: (1) assess the safety and feasibility of a pulmonary vein isolation plus linear plan (PVI‐LP) combined with VOMEI as a first‐line therapy in patients with PeAF; and (2) evaluate the most effective PFA workflow for mitral isthmus (MI) ablation, comparing a flower‐only approach with a basket + flower strategy integrated with the Faraview system. Methods Between April 2024 and September 2025, 87 consecutive patients with PeAF were referred for PFA using a PVI‐LP strategy combined with VOMEI. The procedural workflow consisted of VOMEI first, followed by left PVI, MI line ablation, roof line ablation, and finally right PVI. At the end of the procedure, both the roof line and the MI line were reassessed after a 15‐min waiting period. All procedures were performed using the Farapulse system. Results Eighty‐seven patients undergoing a PVI‐LP plus VOMEI approach as first‐line therapy were initially included. Marshall vein cannulation or infusion failure occurred in 9/87 patients (10.3%). Thus, 78 patients (89.7%) successfully underwent PFA with the PVI‐LP plus VOMEI approach and were included in the final analysis. Baseline clinical and echocardiographic characteristics were as follows: mean age 70.3 ± 8.9 years, 30.8% women, mean CHA 2 DS 2 ‐VASc score 3.0 ± 1.6, mean left ventricular ejection fraction 59 ± 12%, mean left atrial surface area 26.3 ± 4.5 cm 2 , and mean indexed left atrial volume 51 ± 23 mL/m 2 . Procedural time and fluoroscopy time were 51.9 ± 9 and 12.7 ± 4.5 min for the overall procedure, 9.4 ± 2.9 and 3.3 ± 2.2 min for VOMEI, 4.8 ± 4.7 and 2.7 ± 2.9 min for transseptal puncture, and 22.7 ± 7 and 6.7 ± 2.3 min for PFA, respectively. The rate of 15‐min MI reconnection despite VOMEI decreased from 15/39 (38.5%) in the mitral flower group to 6/39 (15.4%) in the basket + flower + Faraview group, corresponding to an absolute risk reduction of 23.1% (95% CI: 4.1%–42.1%), a relative risk of 0.40 (95% CI: 0.17–0.92), and an unadjusted OR of 0.29 (95% CI: 0.10–0.86). Additional applications were delivered whenever MI conduction recovered, until durable bidirectional block was re‐established. At the end of the procedure, the mean total number of PFA applications was 60.3 ± 9.3: 34.4 ± 3.5 for PVI, 8.7 ± 2.9 for the roof line, and 17.1 ± 6.4 for the mitral line. Acute complications included one nitrate‐reversible coronary spasm during the early phase and one acute pericardial tamponade requiring pericardiocentesis. At mid‐term follow‐up (11 ± 3 months), freedom from any atrial arrhythmia after the blanking period was 80.7%. Recurrences included PeAF in six patients, pAF in four, left atrial flutter in four, and right atrial flutter in one. Conclusion This real‐world prospective cohort study shows that de novo PFA using the PVI‐LP plus VOMEI approach is feasible and safe, with a notably short procedural duration. Acute MI reconnection appears to depend on the specific PFA workflow strategy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
努力搬砖的小胡完成签到,获得积分10
1秒前
稳重的元瑶完成签到,获得积分10
1秒前
马亚斌完成签到,获得积分20
2秒前
瓦松完成签到,获得积分20
3秒前
等风归完成签到,获得积分10
3秒前
云朝完成签到,获得积分10
4秒前
5秒前
5秒前
ZeKaWa的应助被liu采纳,获得10
5秒前
PEACE完成签到 ,获得积分20
5秒前
儒雅黑猫完成签到 ,获得积分10
5秒前
6秒前
思恩Shen发布了新的文献求助10
6秒前
秦风完成签到,获得积分10
7秒前
杜欣悦发布了新的文献求助10
7秒前
香蕉觅云的应助被顺利毕业mpa采纳,获得10
7秒前
94完成签到,获得积分10
7秒前
fighting完成签到,获得积分10
8秒前
9秒前
9秒前
哈47发布了新的文献求助10
10秒前
俭朴含卉完成签到 ,获得积分10
10秒前
饼饼完成签到,获得积分20
10秒前
虚幻明杰完成签到,获得积分10
10秒前
Johnny发布了新的文献求助10
11秒前
wxz1998完成签到,获得积分10
11秒前
O基米德发布了新的文献求助10
11秒前
12秒前
田様的应助被木头采纳,获得10
12秒前
吱哦周完成签到,获得积分10
15秒前
16秒前
Diamond完成签到,获得积分10
16秒前
饼饼发布了新的文献求助10
16秒前
17秒前
秋风的应助被紧张的紫文采纳,获得10
18秒前
18秒前
思恩Shen完成签到,获得积分20
19秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621